시장보고서
상품코드
1274839

세계의 반려동물용 의약품 시장 : 동물, 투여 경로, 제품, 지역별 - 시장 규모, 점유율, 동향 분석, 기회, 예측(2019-2029년)

Companion Animal Pharmaceuticals Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Animal ; By Route of Administration ; By Product ; By Region

발행일: | 리서치사: Blueweave Consulting & Research Private Limited | 페이지 정보: 영문 400 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 반려동물용 의약품 시장 규모는 2022년 348억 달러에서 예측 기간 중 4.42%의 CAGR로 추이하며, 2029년에는 451억 2,000만 달러 규모로 성장할 것으로 예측됩니다.

시장의 주요 성장 촉진요인으로는 애완동물 사육 수의 증가, 애완동물 질병의 유병률 상승, 애완동물 건강의 중요성에 대한 인식의 향상 등을 들 수 있습니다. 또한 동물 건강에 대한 지출의 증가에 수반하는 애완동물 보험 수요의 급증, 동물 헬스케어에 관한 R&D 투자의 증가, 세계의 높은 애완동물 사육률 등도 예측 기간 중 시장을 한층 더 촉진할 것으로 기대되고 있습니다.

세계의 반려동물용 의약품 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 분석, 기술 동향, 법규제 환경, 시장 규모의 추이·예측, 각종 구분·지역/주요 국가별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 조사 프레임워크

제2장 주요 요약

제3장 세계의 반려동물용 의약품 시장에 관한 인사이트

  • 산업의 밸류체인 분석
  • DROC 분석
    • 촉진요인
    • 억제요인
    • 기회
    • 과제
  • 제품의 진보/최근 개발
  • 규제 프레임워크
  • Porter's Five Forces 분석

제4장 세계의 반려동물용 의약품 시장 : 개요

  • 시장 규모·예측
  • 시장 점유율·예측
    • 동물별
      • 고양이
      • 기타
    • 투여 경로별
      • 경구
      • 주사
      • 국소
    • 제품별
      • 항생제
      • 항염증약
      • 구충제
      • 백신
      • 기타
    • 지역별
      • 북미
      • 유럽
      • 아시아태평양
      • 라틴아메리카
      • 중동 및 아프리카

제5장 북미의 반려동물용 의약품 시장

  • 시장 규모·예측
  • 시장 점유율·예측
    • 동물별
    • 투여 경로별
    • 제품별
    • 국가별

제6장 유럽의 반려동물용 의약품 시장

  • 시장 규모·예측
  • 시장 점유율·예측
    • 동물별
    • 투여 경로별
    • 제품별
    • 국가별

제7장 아시아태평양의 반려동물용 의약품 시장

  • 시장 규모·예측
  • 시장 점유율·예측
    • 동물별
    • 투여 경로별
    • 제품별
    • 국가별

제8장 라틴아메리카의 반려동물용 의약품 시장

  • 시장 규모·예측
  • 시장 점유율·예측
    • 동물별
    • 투여 경로별
    • 제품별
    • 국가별

제9장 중동 및 아프리카의 반려동물용 의약품 시장

  • 시장 규모·예측
  • 시장 점유율·예측
    • 동물별
    • 투여 경로별
    • 제품별
    • 국가별

제10장 경쟁 구도

  • 주요 기업·제품 리스트
  • 시장 점유율 분석
  • 경쟁 벤치마킹 : 경영 파라미터별
  • 주요 전략적 개발(M&A·제휴 등)

제11장 세계의 반려동물용 의약품 시장에 대한 COVID-19의 영향

제12장 기업 개요(기업 개요·재무 매트릭스·경쟁 구도·주요 인재·주요 경쟁 상대·연락처·전략적 전망·SWOT 분석)

  • Zoetis Inc.
  • Merck Animal Health
  • Boehringer Ingelheim International GmbH
  • Elanco Animal Health Incorporated
  • Bayer AG
  • Virbac
  • Dechra Pharmaceuticals PLC
  • Vetoquinol SA
  • Ceva Sante Animale
  • Kindred Biosciences, Inc.
  • Norbrook
  • IDEXX Laboratories, Inc.
  • Animalcare Group plc
  • Neogen Corporation
  • Heska Corporation
  • 기타 주요 기업

제13장 주요 전략적 제안

제14장 조사 방법

KSA 23.05.25

Global Companion Animal Pharmaceuticals Market Size Set to Touch USD 45.12 Billion by 2029.

Global companion animal pharmaceuticals market is flourishing because of an increasing awareness about animal health and wellness, rising pet ownership, increasing humanization of pets, and growing adoption of technology advancements in veterinary healthcare.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global companion animal pharmaceuticals market size at USD 34.8 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global companion animal pharmaceuticals market size to grow at a CAGR of 4.42% reaching a value of USD 45.12 billion by 2029. Major growth drivers for the global companion animal pharmaceuticals market include an increasing number of pet adoptions, the rising prevalence of pet diseases, and the growing awareness of the importance of pet health. Also, a surge in demand for pet insurance owing to the rising expenditure on animal health, escalating investments in R&D for animal healthcare, and high rates of pet ownership across the globe are expected to further drive the global market during the period in analysis. However, stringent regulations and lengthy approval processes for animal pharmaceuticals and high costs associated with veterinary drugs and treatments are anticipated to hinder the global market during the forecast period.

Global Companion Animal Pharmaceuticals Market - Overview:

A companion animal differs from an assistive animal in that it does not receive any specific training to help a person with a disability. Instead, companion animals provide humans with companionship, entertainment, emotional support, and other functions that humans need from animals. Veterinarians who specialize in companion animals can perform a range of medical services, including treating injuries and illnesses, performing surgeries, administering vaccines, and prescribing medications. They are also responsible for euthanizing animals when necessary. The owners of companion animals are responsible for the animal's well-being, actions, and care. When choosing a companion animal, it is essential to consider the owner's lifestyle, budget, and ability to provide proper care throughout the animal's life. Animal health products, such as feeds, are the most commonly used products for animal healthcare, and this market includes pharmaceuticals and vaccines that improve the health and welfare of animals. Animals obtain nutrition from these products. In recent years, the number of people who own and spend money on companion animals has increased, and pet owners now spend more money per pet than in the past. Pet owners prioritize their pet's health and wellness and expect them to live a healthy life.

Impact of COVID-19 on Global Companion Animal Pharmaceuticals Market

COVID-19 pandemic had a dual impact on the global companion animal pharmaceuticals market. On the positive side, with lockdowns and social distancing measures in place, people were spending more time at home and turning to pets for comfort and companionship. It led to an increase in pet ownership and a surge in demand for animal healthcare products and services, including pharmaceuticals. However, on the negative side, the pandemic disrupted global supply chains and manufacturing activities, causing shortages of raw materials and finished products. It led to production delays and increased prices, which affected the profitability of the market players. Moreover, with the focus on human healthcare during the pandemic, veterinary care and services were deprioritized in some regions, leading to a decline in demand for companion animal pharmaceuticals. Despite these challenges, the overall impact of the pandemic on the companion animal pharmaceuticals market was relatively moderate, and the market is expected to recover as the situation normalizes. As people continue to value the companionship of their pets, the demand for animal healthcare products and services is expected to remain robust in the long term.

Global Companion Animal Pharmaceuticals Market - By Animal

By animal, the global companion animal pharmaceuticals market is divided into Dogs, Cats, and Horses segments. The dogs segment held the highest share in the global companion animal pharmaceuticals market in 2022. According to Holland Insurance Company Pty. Ltd., India is experiencing an exponential growth in its pet dog population, driven by urbanization and millennials opting for dogs as pets. Also, the growing awareness of pet insurance and animal health importance is expected to boost the market growth. On the other hand, the cats' segment is projected to grow at the highest compound annual growth rate (CAGR) during the forecast period. Cats are becoming increasingly popular in certain countries like Canada and are preferred over dogs. Additionally, many companies are concentrating on expanding their product range for cats due to their greater susceptibility to diseases when compared to other pets.

Competitive Landscape:

Major players operating in the global companion animal pharmaceuticals market include: Nestle SA, The Hershey Company, Lindt & Sprungli AG, Mondelez International, Inc., Ferrero Group, Haribo GmbH & Co. KG, Perfetti Van Melle, Russell Stover Chocolates, Wrigley Jr. Company, Ricola AG, Chupa Chups SA, Jelly Belly Candy Company, Lotte Group, Swizzels Matlow Limited, and The Topps Company. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Companion Animal Pharmaceuticals Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Companion Animal Pharmaceuticals Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Companion Animal Pharmaceuticals Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing pet ownership and increasing humanization of pets
      • 3.2.1.2. Rising awareness about animal health and wellness
      • 3.2.1.3. Advancements in veterinary healthcare technology
    • 3.2.2. Restraints
      • 3.2.2.1. Stringent regulations and lengthy approval processes for animal pharmaceuticals
      • 3.2.2.2. High costs associated with veterinary drugs and treatments
    • 3.2.3. Opportunities
      • 3.2.3.1. Increasing demand for personalized and customized medicine for pets
      • 3.2.3.2. Rising trend of pet insurance, providing financial assistance for pet healthcare
    • 3.2.4. Challenges
      • 3.2.4.1. Concerns over the safety and efficacy of animal pharmaceuticals
      • 3.2.4.2. Lack of awareness and education about pet healthcare in certain regions
  • 3.3. Product Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Companion Animal Pharmaceuticals Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Animal
      • 4.2.1.1. Dogs
      • 4.2.1.2. Cats
      • 4.2.1.3. Horses
      • 4.2.1.4. Others
    • 4.2.2. By Route of Administration
      • 4.2.2.1. Oral
      • 4.2.2.2. Injectable
      • 4.2.2.3. Topical
    • 4.2.3. By Product
      • 4.2.3.1. Antibiotics
      • 4.2.3.2. Anti-inflammatory
      • 4.2.3.3. Parasiticides
      • 4.2.3.4. Vaccines
      • 4.2.3.5. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Companion Animal Pharmaceuticals Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal
    • 5.2.2. By Route of Administration
    • 5.2.3. By Product
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Animal
      • 5.2.4.1.2. By Route of Administration
      • 5.2.4.1.3. By Product
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Animal
      • 5.2.4.2.2. By Route of Administration
      • 5.2.4.2.3. By Product

6. Europe Companion Animal Pharmaceuticals Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal
    • 6.2.2. By Route of Administration
    • 6.2.3. By Product
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Animal
      • 6.2.4.1.2. By Route of Administration
      • 6.2.4.1.3. By Product
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Animal
      • 6.2.4.2.2. By Route of Administration
      • 6.2.4.2.3. By Product
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Animal
      • 6.2.4.3.2. By Route of Administration
      • 6.2.4.3.3. By Product
      • 6.2.4.4. France
      • 6.2.4.4.1. By Animal
      • 6.2.4.4.2. By Route of Administration
      • 6.2.4.4.3. By Product
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Animal
      • 6.2.4.5.2. By Route of Administration
      • 6.2.4.5.3. By Product
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Animal
      • 6.2.4.6.2. By Route of Administration
      • 6.2.4.6.3. By Product
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Animal
      • 6.2.4.7.2. By Route of Administration
      • 6.2.4.7.3. By Product
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Animal
      • 6.2.4.8.2. By Route of Administration
      • 6.2.4.8.3. By Product
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Animal
      • 6.2.4.9.2. By Route of Administration
      • 6.2.4.9.3. By Product

7. Asia-Pacific Companion Animal Pharmaceuticals Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal
    • 7.2.2. By Route of Administration
    • 7.2.3. By Product
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Animal
      • 7.2.4.1.2. By Route of Administration
      • 7.2.4.1.3. By Product
      • 7.2.4.2. India
      • 7.2.4.2.1. By Animal
      • 7.2.4.2.2. By Route of Administration
      • 7.2.4.2.3. By Product
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Animal
      • 7.2.4.3.2. By Route of Administration
      • 7.2.4.3.3. By Product
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Animal
      • 7.2.4.4.2. By Route of Administration
      • 7.2.4.4.3. By Product
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Animal
      • 7.2.4.5.2. By Route of Administration
      • 7.2.4.5.3. By Product
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Animal
      • 7.2.4.6.2. By Route of Administration
      • 7.2.4.6.3. By Product
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Animal
      • 7.2.4.7.2. By Route of Administration
      • 7.2.4.7.3. By Product
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Animal
      • 7.2.4.8.2. By Route of Administration
      • 7.2.4.8.3. By Product
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Animal
      • 7.2.4.9.2. By Route of Administration
      • 7.2.4.9.3. By Product
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Animal
      • 7.2.4.10.2. By Route of Administration
      • 7.2.4.10.3. By Product

8. Latin America Companion Animal Pharmaceuticals Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal
    • 8.2.2. By Route of Administration
    • 8.2.3. By Product
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Animal
      • 8.2.4.1.2. By Route of Administration
      • 8.2.4.1.3. By Product
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Animal
      • 8.2.4.2.2. By Route of Administration
      • 8.2.4.2.3. By Product
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Animal
      • 8.2.4.3.2. By Route of Administration
      • 8.2.4.3.3. By Product
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Animal
      • 8.2.4.4.2. By Route of Administration
      • 8.2.4.4.3. By Product
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Animal
      • 8.2.4.5.2. By Route of Administration
      • 8.2.4.5.3. By Product

9. Middle East & Africa Companion Animal Pharmaceuticals Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal
    • 9.2.2. By Route of Administration
    • 9.2.3. By Product
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Animal
      • 9.2.4.1.2. By Route of Administration
      • 9.2.4.1.3. By Product
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Animal
      • 9.2.4.2.2. By Route of Administration
      • 9.2.4.2.3. By Product
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Animal
      • 9.2.4.3.2. By Route of Administration
      • 9.2.4.3.3. By Product
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Animal
      • 9.2.4.4.2. By Route of Administration
      • 9.2.4.4.3. By Product
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Animal
      • 9.2.4.5.2. By Route of Administration
      • 9.2.4.5.3. By Product
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Animal
      • 9.2.4.6.2. By Route of Administration
      • 9.2.4.6.3. By Product
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Animal
      • 9.2.4.7.2. By Route of Administration
      • 9.2.4.7.3. By Product
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Animal
      • 9.2.4.8.2. By Route of Administration
      • 9.2.4.8.3. By Product

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Companion Animal Pharmaceuticals Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Companion Animal Pharmaceuticals Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Zoetis Inc.
  • 12.2. Merck Animal Health
  • 12.3. Boehringer Ingelheim International GmbH
  • 12.4. Elanco Animal Health Incorporated
  • 12.5. Bayer AG
  • 12.6. Virbac
  • 12.7. Dechra Pharmaceuticals PLC
  • 12.8. Vetoquinol SA
  • 12.9. Ceva Sante Animale
  • 12.10. Kindred Biosciences, Inc.
  • 12.11. Norbrook
  • 12.12. IDEXX Laboratories, Inc.
  • 12.13. Animalcare Group plc
  • 12.14. Neogen Corporation
  • 12.15. Heska Corporation
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제